» Articles » PMID: 29423046

Vitexin Induces Apoptosis by Suppressing Autophagy in Multi-drug Resistant Colorectal Cancer Cells

Overview
Journal Oncotarget
Specialty Oncology
Date 2018 Feb 10
PMID 29423046
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer treatment is limited due to the diverse multidrug resistance acquired by cancer cells and the collateral damage caused to adjacent normal cells by chemotherapy. The flavonoid compound vitexin exhibits anti-oxidative, anti-inflammatory and anti-tumor activity. This study elucidated the antitumor effects of vitexin and its underlying mechanisms in a multi-drug resistant human colon cancer cell line (HCT-116), which exhibits higher levels of multidrug-resistant protein 1 (MDR1) expression as compared with its parental cell line (HCT-116). Here, we observed that vitexin suppressed MDR-1 expression and activity in HCT-116 cells and showed cytotoxic effect in HCT-116 cells by inhibiting autophagy and inducing apoptosis in a concentration-dependent manner. Additionally, vitexin treatment caused cleavage of caspase-9 and caspase-3, and upregulated the expression of the pro-apoptotic proteins, BID and Bax. Moreover, the expression of autophagy-related proteins, such as ATG5, Beclin-1 and LC3-II, was markedly reduced by vitexin treatment. Furthermore, experiments showed that vitexin induced apoptosis and suppressed tumor growth in HCT-116 xenograft model. These results revealed that vitexin induced apoptosis through suppression of autophagy and and provide insight into the therapeutic potential of vitexin for the treatment of chemo-resistant colorectal cancer.

Citing Articles

The superiority of PMFs on reversing drug resistance of colon cancer and the effect on aerobic glycolysis-ROS-autophagy signaling axis.

Yin Y, Wu Y, Huang H, Duan Y, Yuan Z, Cao L Oncol Res. 2024; 32(12):1891-1902.

PMID: 39574478 PMC: 11576955. DOI: 10.32604/or.2024.048778.


Progress in the study of anti-tumor effects and mechanisms of vitexin.

Yang Q, Huan R, Meng D, Qi J, Xia L Pharmacol Rep. 2024; 77(1):124-134.

PMID: 39477892 DOI: 10.1007/s43440-024-00664-8.


The Potential Anticancer Potency of Kolaviron on Colorectal Adenocarcinoma (Caco-2) Cells.

Althagafi H Anticancer Agents Med Chem. 2024; 24(15):1097-1108.

PMID: 38835121 DOI: 10.2174/0118715206288807240527165444.


Apigenin: Molecular Mechanisms and Therapeutic Potential against Cancer Spreading.

Naponelli V, Rocchetti M, Mangieri D Int J Mol Sci. 2024; 25(10).

PMID: 38791608 PMC: 11122459. DOI: 10.3390/ijms25105569.


Network-Pharmacology-Based Study on Active Phytochemicals and Molecular Mechanism of Cnidii Fructus in Treating Colorectal Cancer.

Wei Z, Zhang X, Peng A, Liu C, Pang J, Zhang Y Comb Chem High Throughput Screen. 2023; 27(18):2667-2680.

PMID: 37861043 DOI: 10.2174/0113862073273396231010102606.


References
1.
Szakacs G, Paterson J, Ludwig J, Booth-Genthe C, Gottesman M . Targeting multidrug resistance in cancer. Nat Rev Drug Discov. 2006; 5(3):219-34. DOI: 10.1038/nrd1984. View

2.
Dai C, Whitesell L, Rogers A, Lindquist S . Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell. 2007; 130(6):1005-18. PMC: 2586609. DOI: 10.1016/j.cell.2007.07.020. View

3.
Halliwell B . Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies?. Arch Biochem Biophys. 2008; 476(2):107-12. DOI: 10.1016/j.abb.2008.01.028. View

4.
Azzaria M, Schurr E, Gros P . Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance. Mol Cell Biol. 1989; 9(12):5289-97. PMC: 363693. DOI: 10.1128/mcb.9.12.5289-5297.1989. View

5.
Kioka N, Yamano Y, Komano T, Ueda K . Heat-shock responsive elements in the induction of the multidrug resistance gene (MDR1). FEBS Lett. 1992; 301(1):37-40. DOI: 10.1016/0014-5793(92)80205-u. View